Ireland an outlier without access to new cell and gene therapy, report says

The Irish Times

27 May 2021 - Upfront costs high but treatments may cut long-term expense and boost patient results.

Irish patients will not be able to access expensive cutting-edge medicines without a rethink of the reimbursement model used to pay for new treatments, according to a report published on Thursday.

Ireland is currently almost alone among western European countries in not granting patients access to modern cell and gene therapy treatments, it says.

Read The Irish Times article

Michael Wonder

Posted by:

Michael Wonder